Log in to save to my catalogue

Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, p...

Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, p...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2460982981

Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial

About this item

Full title

Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial

Publisher

England: Elsevier Ltd

Journal title

Lancet neurology, 2020-12, Vol.19 (12), p.980-987

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Despite intracerebral haemorrhage causing 5% of deaths worldwide, few evidence-based therapeutic strategies other than stroke unit care exist. Tranexamic acid decreases haemorrhage in conditions such as acute trauma and menorrhoea. We aimed to assess whether tranexamic acid reduces intracerebral haemorrhage growth in patients with acute intracerebr...

Alternative Titles

Full title

Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2460982981

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2460982981

Other Identifiers

ISSN

1474-4422

E-ISSN

1474-4465

DOI

10.1016/S1474-4422(20)30369-0

How to access this item